Marta Sánchez Pérez

Institutions of which they are part

Diabetes and Metabolism

Vall Hebron Institut de Recerca

Marta Sánchez Pérez

Institutions of which they are part

Diabetes and Metabolism

Vall Hebron Institut de Recerca

Related news

Equip del grup de Diabetis i Metabolisme del VHIR

Fundaluce supports research into a new therapeutic strategy for retinitis pigmentosa

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

We study fatty liver and cardiovascular complications with digital twins

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

The Vall d'Hebron spin-off D-Sight is awarded in EIT Health Innostars 2023 competition

This investment from EIT Health in the project will enable D-Sight to progress in the clinical development of its groundbreaking treatment for the early stages of diabetic retinopathy.